Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-14-037802
Filing Date
2014-12-03
Accepted
2014-12-03 17:42:25
Documents
1
Period of Report
2014-12-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 - CHRISTOPHER ALAFI, PH.D. rrd419644.html 4  
1 FORM 4 - CHRISTOPHER ALAFI, PH.D. rrd419644.xml 4 5107
  Complete submission text file 0001181431-14-037802.txt   6521
Mailing Address P.O. BOX 7338 BERKELEY CA 94707
Business Address
Alafi Christopher D (Reporting) CIK: 0001299430 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36274 | Film No.: 141264518

Mailing Address 3960 BROADWAY NEW YORK NY 10032
Business Address 3960 BROADWAY NEW YORK NY 10032 212-923-3344
Intra-Cellular Therapies, Inc. (Issuer) CIK: 0001567514 (see all company filings)

EIN.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations